|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
Activation of the inducible transcription factor nuclear factor
B (NF-
B) occurs in cells exposed to oxidative stress, and the serine/threonine kinase protein kinase D (PKD) is critical for signal relay to NF-
B. We have recently delineated two coordinated events that control PKD activation in response to oxidative stress: phosphorylation at Tyr463 by the tyrosine kinase Abl, and phosphorylation at the activation loop Ser738/Ser742 by the protein kinase C (PKC) isoform PKC
. The result is fully active PKD that controls NF-
B activation through the I
B kinase (IKK) complex. Here, we investigate the mechanism by which PKD controls IKK/NF-
B activation. Resveratrol, a potent antioxidant, blocks both PKD activation and NF-
B induction. In particular, resveratrol blocked PKD activation loop phosphorylation and activity, and this was caused by a specific inhibition of the Ser738/Ser742 kinase PKC
. On the other hand, resveratrol did not affect Abl kinase activity and had no effect on Tyr463 phosphorylation. Moreover, we show that the mechanism by which resveratrol inhibits NF-
B is by blocking the translocation of PKD to the IKK complex, specifically by inhibiting Ser738/Ser742 phosphorylation. We therefore propose that rather than acting as an antioxidant, resveratrol specifically blocks oxidative stress-dependent NF-
B activation by interfering with PKD phosphorylation and association with the IKK complex.
Address correspondence to: Dr. Alex Toker, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215. E-mail: atoker{at}bidmc.harvard.edu
This article has been cited by other articles:
![]() |
S. A. Buder-Hoffmann, A. Shukla, T. F. Barrett, M. B. MacPherson, K. M. Lounsbury, and B. T. Mossman A Protein Kinase C{delta}-Dependent Protein Kinase D Pathway Modulates ERK1/2 and JNK1/2 Phosphorylation and Bim-Associated Apoptosis by Asbestos Am. J. Pathol., February 1, 2009; 174(2): 449 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. O. Rybin, J. Guo, and S. F. Steinberg Protein Kinase D1 Autophosphorylation via Distinct Mechanisms at Ser744/Ser748 and Ser916 J. Biol. Chem., January 23, 2009; 284(4): 2332 - 2343. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yuan, A. Lugea, L. Zheng, I. Gukovsky, M. Edderkaoui, E. Rozengurt, and S. J. Pandol Protein kinase D1 mediates NF-{kappa}B activation induced by cholecystokinin and cholinergic signaling in pancreatic acinar cells Am J Physiol Gastrointest Liver Physiol, December 1, 2008; 295(6): G1190 - G1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Doppler and P. Storz A Novel Tyrosine Phosphorylation Site in Protein Kinase D Contributes to Oxidative Stress-mediated Activation J. Biol. Chem., November 2, 2007; 282(44): 31873 - 31881. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Chiu, W. Y. Leung, M. P. Moyer, R. M. Strieter, and E. Rozengurt Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in nontransformed human colonic epithelial cells through NF-{kappa}B Am J Physiol Cell Physiol, February 1, 2007; 292(2): C767 - C777. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lin, M. A. Glenn, R. J. Harris, A. D. Duckworth, S. Dennett, J. C. Cawley, M. Zuzel, and J. R. Slupsky c-Abl Expression in Chronic Lymphocytic Leukemia Cells: Clinical and Therapeutic Implications. Cancer Res., August 1, 2006; 66(15): 7801 - 7809. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Song, J. Li, A. Lulla, B. M. Evers, and D. H. Chung Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-{delta} pathway activation Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1469 - C1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, S. Zheng, P. Storz, and W. Min Protein Kinase D Specifically Mediates Apoptosis Signal-regulating Kinase 1-JNK Signaling Induced by H2O2 but Not Tumor Necrosis Factor J. Biol. Chem., May 13, 2005; 280(19): 19036 - 19044. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rozengurt, O. Rey, and R. T. Waldron Protein Kinase D Signaling J. Biol. Chem., April 8, 2005; 280(14): 13205 - 13208. [Full Text] [PDF] |
||||
![]() |
C. D. Wood, U. Marklund, and D. A. Cantrell Dual Phospholipase C/Diacylglycerol Requirement for Protein Kinase D1 Activation in Lymphocytes J. Biol. Chem., February 18, 2005; 280(7): 6245 - 6251. [Abstract] [Full Text] [PDF] |
||||